Ouro Medicines (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- January 10, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $120,000,000
Company Info
- Traction
- Raised $120 million in Series A funding.
- Organizations Involved
- GSK, Monograph Capital, NEA, TPG Life Sciences Innovations
- Founders
- Jaideep Dudani
- Company Description
- Ouro Medicines is a biotechnology startup focused on developing antibody drugs for chronic inflammatory conditions using T cell engagers to rebalance the immune systems of people with autoimmune diseases.
- Market
- Autoimmune diseases
- Location
- USA
- Coinvestors
- GSK, Monograph Capital, NEA, TPG Life Sciences Innovations